Abstract
Within the ventromedial nucleus of the hypothalamus (VMN), serotonin exerts a dual role in the control of female rat lordosis behavior. Most emphasis has been placed on 5-HT 1A and 5-HT 2 receptors, which inhibit and facilitate the behavior, respectively. In the current experiment, a potential role for VMN 5-HT 3 receptors in the control of lordosis behavior was examined. Ovariectomized rats, hormonally primed with 25 μg estradiol benzoate and 500 μg progesterone, received bilateral VMN infusions with 100 ng, 250 ng or 500 ng of the 5-HT 3 receptor antagonist, tropisetron. In these rats, there was a dose-dependent decline in both the lordosis to mount (L/M) ratio and in the quality of the lordosis reflex with 500 ng tropisetron producing the most consistent change in lordosis behavior. Relative to hormone-primed, ovariectomized rats, lordosis behavior of proestrous females was less affected by VMN infusions with the 5-HT 3 receptor antagonist. The 5-HT 3 receptor agonist, m-chlorophenylbiguanide (mCPBG), attenuated the effect of tropisetron; of the three mCPBG doses (500 ng, 1000 ng, 1500 ng) examined, 1000 ng was the most effective, perhaps because, alone, 1500 ng mCPBG slightly reduced lordosis behavior. These observations emphasize the potential role for VMN 5-HT 3 receptors in the control of lordosis behavior.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
